Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Senior Leaders from Google Confirmed to Speak at BIOMEDevice Silicon Valley ?Smart Event'


BIOMEDevice Silicon Valley, the must-attend regional event connecting biotech engineers and cutting-edge companies formerly known as BIOMEDevice San Jose, today announced the event's return to Northern California December 8-9, 2021 at the San Jose McEnery Convention Center. New for 2021, BIOMEDevice will be a Smart Event, giving the registered audience access to exclusive webinars, robust supplier profiles, product information, meeting scheduling and networking before and after the live event.

By registering now, attendees can access the Smart Event when the online platform launches on November 8 and engage with world-class biotech speakers and content, available every Wednesday leading up to the live event. Mark your calendars now for the November 17 session presented by industry leaders at Google.

Monitoring Real-World Performance of Healthcare AI
Speakers: Jay Nayer, Senior Regulatory Affairs Specialist at Google; Anne Zhang, Senior Software Engineer at Google; and Lu Yang, Software Engineer at Google

Overview: The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. The plan outlines a holistic approach based on total product lifecycle oversight to further the enormous potential these technologies have to improve patient care while delivering safe and effective software functionality that improves patients' quality of care.

A key principle of the plan is to gather performance data on the real-world use of the SaMD. If you are new to this type of product development or are working on more complex systems, this presentation will help you understand some of the tools that Google is developing to use big data effectively.

"The Smart Event model is a gamechanger for the engineers and industry professionals seeking an enhanced experience beyond the constraints of two days at the live event," said Adrienne Zepeda, Group Event Director, BIOMEDevice Silicon Valley, Informa Markets. "In-person connection is absolutely critical to establishing business partnerships in this industry, but what's just as important is the opportunity to have time to research suppliers and products in advance and nurture new relationships after the fact."

Zepeda continued: "We've melded two proven event models ? virtual and in-person ? for an all-encompassing hybrid experience that makes the time spent onsite in San Jose more productive and efficient."

With many of the industry's most prominent companies signed on already, including Qosina, Nelson Labs and B. Braun OEM Division, the event is gearing up to be the most robust exhibition and conference to date. Visit www.biomedevicesiliconvalley.com for new educational content available in the digital platform over the course of the next few weeks.

Press interested in participating can secure a free Media Pass here.

Follow BIOMEDevice Silicon Valley on social #BIOMEDevicesSmartEvent

About Informa Markets ? Engineering:

Informa Markets' Engineering portfolio is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa, the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them thrive 365 days of the year. For more information, please visit www.informamarkets.com.

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio comprises more than 550 international B2B events and brands in markets including Engineering, Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and, do business through face-to-face exhibitions, specialist digital content and, actionable data solutions. As the world's leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.


These press releases may also interest you

26 nov 2021
The unmanned underwater vehicles market size is expected to increase by USD 1.91 bn from 2020 to 2025, according to the latest research report from Technavio. The growth momentum of the market is expected to decelerate at a CAGR of 13.77%. This...

26 nov 2021
The cold storage market size is expected to increase by USD 31.97 bn from 2020 to 2025, registering a CAGR of  2.79%, according to the latest research report from Technavio. This exclusive report describes market scenarios, estimates, and customer...

26 nov 2021
The online apparel retailing market and is set to grow by USD 87.45 billion from 2020 to 2025, progressing at a CAGR of 10.61%  according to the latest report by Technavio....

26 nov 2021
Cepton Technologies, Inc. ("Cepton"), a Silicon Valley innovator focused on the mass-market commercialization of high performance, high quality lidar solutions, announced today that it and Growth Capital Acquisition Corp ("GCAC") have entered into a...

26 nov 2021
The K-12 game-based learning market is set to grow by USD 9.03 billion from 2020 to 2025, progressing at a CAGR of 20.63%  according to Technavio. 37% of the market's growth will originate from North America. The US and Canada are the key markets for...

26 nov 2021
Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a biotechnology company focused on progressing "Psychedelics to Therapeuticstm", is pleased to announce that Adelia Therapeutics Inc. ("Adelia"), a wholly-controlled subsidiary of Cybin, has achieved...



News published on 21 october 2021 at 11:35 and distributed by: